BeiGene to Present at the Morgan Stanley 20th Annual Global Healthcare Conference
08 September 2022 - 9:27AM
Business Wire
BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a
global biotechnology company focused on developing and
commercializing innovative and affordable oncology medicines to
improve treatment outcomes and access for patients worldwide, today
announced that the Company will participate in the Morgan Stanley
20th Annual Global Healthcare Conference on Wednesday, September
14th, 2022 with a fireside chat at 9:10 a.m. ET.
A live webcast can be accessed from the investors section of
BeiGene’s website at http://ir.beigene.com. An archived replay will
be available for 90 days following the event.
About BeiGene BeiGene is a global biotechnology company
that is developing and commercializing innovative and affordable
oncology medicines to improve treatment outcomes and access for far
more patients worldwide. With a broad portfolio, we are expediting
development of our diverse pipeline of novel therapeutics through
our internal capabilities and collaborations. We are committed to
radically improving access to medicines for far more patients who
need them. Our growing global team of more than 8,500 colleagues
spans five continents, with administrative offices in Beijing,
China; Cambridge, U.S.; and Basel, Switzerland. To learn more about
BeiGene, please visit www.beigene.com and follow us on Twitter at
@BeiGeneGlobal.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220907006312/en/
Investors Kevin Mannix +1-857-302-5189 ir@beigene.com
Media Emily Collins +1-201-201-4570 media@beigene.com
BeiGene (NASDAQ:BGNE)
Historical Stock Chart
From Jun 2024 to Jul 2024
BeiGene (NASDAQ:BGNE)
Historical Stock Chart
From Jul 2023 to Jul 2024